Hepatitis C Virus Re-Treatment in the Era of Direct-Acting Antivirals: Projections in the USA

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14527
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Coinfection With Hepatitis B and Hepatitis C Virus: New Insights of Treatment in the Era of Direct Acting Antivirals.

International Journal of Advanced Research
2017English

Hepatitis C Related Hepatocellular Carcinoma in the Era of Direct-Acting Antivirals

Hepatoma Research
2018English

Hepatitis C Infected Patients Need Vitamin D3 Supplementation in the Era of Direct Acting Antivirals Treatment

World Journal of Gastroenterology
MedicineGastroenterology
2017English

Direct‐Acting Antivirals in Hepatitis C Virus‐Associated Diffuse Large B‐cell Lymphomas

Oncologist
Cancer ResearchMedicineOncology
2018English

Treating Hepatitis B Virus/Hepatitis C Virus Coinfected Patients With Direct-Acting Hepatitis C Virus Antivirals Only Is Not Safe

Hepatology
MedicineHepatology
2016English

Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis

Scientifica
AgriculturalEnvironmental ScienceBiological Sciences
2012English

Direct-Acting Antivirals for the Treatment of Hepatitis C Virus Infection: Optimizing Current IFN-free Treatment and Future Perspectives

Liver International
Hepatology
2016English

Hepatocellular Carcinoma Decreases the Chance of Successful Hepatitis C Virus Therapy With Direct-Acting Antivirals

Journal of Hepatology
Hepatology
2017English

The Interplay Between Direct-Acting Antivirals and Hepatocellular Carcinoma in Chronic Hepatitis C

Hepatoma Research
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy